Classifies xylazine as a schedule III controlled drug in New Hampshire.
New Hampshire SB465 amends the Controlled Drug Act to classify xylazine as a schedule III controlled drug. This change takes effect January 1, 2027. The bill allows licensed veterinarians to continue their practices involving xylazine. The classification aims to regulate the drug more strictly, affecting its distribution and use within the state.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.